We have an eye on vision research to redefine noninvasive ocular therapeutics.  Our goal is to provide ophthalmology professionals greater freedom and treatment options to provide optimal care for their patients.  Our world renowned research team is focused on developing noninvasive therapeutics for sight threatening diseases of both the anterior and posterior sections of the eye addressing a potential wide range of ocular diseases requiring therapies with drug transport and controlled release challenges.